LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that its representatives plan to attend MEDICA 2026 in Dusseldorf, Germany, one of the world's largest international healthcare and medical technology trade fairs. The company aims to evaluate healthcare technologies, foster strategic industry relationships, and explore commercialization opportunities for its telehealth infrastructure and analytics platforms focused on emerging markets.
Management stated that attendance at MEDICA is intended to support ongoing evaluation of healthcare technologies, vendor solutions, digital infrastructure initiatives, and broader commercialization opportunities. The company plans to engage with healthcare technology providers, telehealth vendors, pharmaceutical infrastructure participants, medical software developers, and AI-focused healthcare companies from Europe, Latin America, and other international markets.
The announcement underscores the company's commitment to advancing its long-term digital healthcare infrastructure strategy across Latin America. Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., said: "Healthcare systems around the world are rapidly moving toward technology-driven and AI-enabled infrastructure models. Our attendance at MEDICA reflects our commitment to engaging with industry participants, evaluating emerging technologies, and continuing to build a scalable healthcare platform designed to support long-term digital healthcare modernization initiatives throughout Latin America."
The company remains in the development and commercialization stage with respect to certain aspects of its healthcare technology platform and business operations. It cautioned that attending industry conferences does not guarantee strategic relationships, commercial agreements, financing, technology integrations, revenue generation, or future operational success.
LataMed AI Corp. is focused on developing scalable telehealth infrastructure and healthcare analytics platforms for emerging markets, with an initial emphasis on Latin America. The company is advancing a technology-enabled healthcare ecosystem to support remote patient engagement, provider coordination, healthcare analytics, emergency response integration, pharmaceutical logistics, and broader digital healthcare delivery initiatives.
For more information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
